News & Insights

BioTech
NVCT

Nuvectis Pharma Prices Public Offering At $5.00 Per Share

February 05, 2025 — 12:54 pm EST

Written by RTTNews.com for RTTNews->

(RTTNews) - Nuvectis Pharma, Inc. (NVCT), a clinical-stage biopharmaceutical company, has priced its underwritten public offering of 2.7 million shares of common stock at $5.00 per share.

The offering, set to close on February 6, 2025, is expected to generate gross proceeds of $13.5 million.

Currently, NVCT is trading at $7.40 up by 5.71%

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

BioTech
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

NVCT

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.